For over two decades, MediSphere has been at the forefront of pharmaceutical innovation, dedicated to advancing human health across the United States and beyond.
MediSphere was founded in New York City in 2000 by a team of visionary pharmaceutical scientists committed to transforming the healthcare landscape. What began as a small research lab has grown into one of the most trusted pharmaceutical companies in the United States.
With headquarters at 1200 Pharma Boulevard in New York, NY, our state-of-the-art facilities span across three states, employing over 2,000 dedicated professionals. Our portfolio encompasses more than 500 products across multiple therapeutic areas.
Today, MediSphere serves over 12 million patients annually, maintaining a 98% quality compliance rate that exceeds industry standards.
To develop innovative medicines that improve human health and enhance the quality of life for patients around the world.
A world where advanced healthcare is accessible to all, empowering healthier communities and transforming lives through scientific excellence.
The principles that guide every decision we make
Unwavering commitment to ethical practices, transparency, and accountability in all operations.
Continuous pursuit of scientific breakthroughs and creative solutions to healthcare challenges.
Rigorous standards and uncompromising quality control across every product and process.
Every decision starts with the patient — their safety, needs, and well-being drive our mission.
Responsible environmental stewardship and sustainable manufacturing practices for future generations.
Visionary leaders driving pharmaceutical excellence
Key milestones in our history of innovation
MediSphere founded in New York City with a mission to revolutionize pharmaceutical development.
Received FDA approval for our first proprietary cardiovascular treatment, marking a major milestone.
Expanded operations nationwide with new manufacturing facilities and distribution centers.
Launched our biotechnology division, pioneering biologic therapies and advanced research.
Achieved ISO 9001:2015 certification and expanded our reach to international markets.
Opened a new R&D center in New Jersey and launched breakthrough products including CardioShield Pro.
Meeting the highest industry standards
All facilities registered and inspected by the U.S. Food and Drug Administration.
Good Manufacturing Practice certification across all manufacturing facilities.
International quality management system certification for operational excellence.
Industry recognition for our contributions to healthcare
American Pharmaceutical Association — 2024
Science Careers Magazine — 2023, 2024
FDA Compliance Council — 2025